INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 387 filers reported holding INSMED INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,681,617 | +92.7% | 114,651 | -22.0% | 0.40% | +85.4% |
| Q1 2024 | $3,985,723 | -6.8% | 146,912 | +6.4% | 0.21% | -12.7% |
| Q4 2023 | $4,277,705 | -0.9% | 138,035 | -19.3% | 0.24% | -11.3% |
| Q3 2023 | $4,317,902 | +130547.6% | 171,006 | +9.2% | 0.28% | +40.3% |
| Q2 2023 | $3,305 | +41.6% | 156,627 | +14.4% | 0.20% | +37.1% |
| Q1 2023 | $2,334 | -9.8% | 136,887 | +5.7% | 0.14% | -10.6% |
| Q4 2022 | $2,587 | -99.9% | 129,481 | -16.5% | 0.16% | -27.3% |
| Q3 2022 | $3,340,000 | +24.6% | 155,064 | +14.1% | 0.22% | +32.5% |
| Q2 2022 | $2,681,000 | -40.4% | 135,950 | -29.0% | 0.17% | -30.5% |
| Q1 2022 | $4,502,000 | -9.3% | 191,582 | +5.2% | 0.24% | -2.0% |
| Q4 2021 | $4,962,000 | -17.4% | 182,173 | -16.5% | 0.24% | -22.8% |
| Q3 2021 | $6,006,000 | -9.5% | 218,082 | -6.5% | 0.32% | -10.7% |
| Q2 2021 | $6,635,000 | -10.5% | 233,143 | +7.1% | 0.35% | -20.4% |
| Q1 2021 | $7,415,000 | – | 217,695 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,429,518 | $34,137,000 | 14.73% |
| Fairmount Funds Management LLC | 988,999 | $23,617,000 | 14.31% |
| Palo Alto Investors LP | 6,848,760 | $163,548,000 | 9.00% |
| Asymmetry Capital Management, L.P. | 113,875 | $2,719,000 | 4.87% |
| First Light Asset Management, LLC | 1,293,548 | $30,890,000 | 3.95% |
| Foresite Capital Management II, LLC | 880,016 | $21,015,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 169,000 | $4,036,000 | 1.00% |
| Ghost Tree Capital, LLC | 200,000 | $4,776,000 | 0.91% |
| EMERALD ADVISERS, LLC | 674,167 | $16,099,000 | 0.68% |
| Granahan Investment Management | 583,717 | $13,939,000 | 0.64% |